NCT04451655View on ClinicalTrials.gov

Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Blood Glucose
Interventions
DRUG

Continuous insulin infusion

This study aims to explore the hypothesis that diabetic patients undergoing coronary artery bypass graft (CABG) surgery receiving intravenous continuous insulin infusion (CII) for tight glycemic control (110-149 mg/dl) protocol during the intraoperative period would have improved intraoperative glycemic stability, efficacy and consistency compared to patients receiving conventional glycemic control (150-180 mg/dl) protocol during the intraoperative period

Trial Locations (1)

Unknown

Jordan royal medical service, Amman

All Listed Sponsors
lead

Audai A. Hayajneh

OTHER

NCT04451655 - Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery | Biotech Hunter | Biotech Hunter